Skip to content

Clinical trials

Glycogen Storage Disease Type II trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glycogen Storage Disease Type II Country / region: United States Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20034
20043
20053
20075
20084
20092
20102
20114
20126
20136
20143
20156
20165
20175
20183
20193
20203
20212
20222
20231
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed49
Recruiting11
Active, not recruiting8
Terminated7
Unknown status4
Withdrawn2
Approved for marketing1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genzyme, a Sanofi Company25
Duke University12
Amicus Therapeutics8
University of Florida7
O & O Alpan LLC3
Sanofi3
AskBio Inc2
Astellas Gene Therapies2
BioMarin Pharmaceutical2
Spark Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glycogen Storage Disease Type II82
Lysosomal Storage Diseases7
Glycogen Storage Disease5
Gaucher Disease4
Fabry Disease3
Macular Degeneration3
Amyotrophic Lateral Sclerosis2
Anemia, Sickle Cell2
Cystic Fibrosis2
Muscular Atrophy, Spinal2

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.